AT396186T
Heteroaryl substituted tetrazole modulators of metabotropic glutamate receptor-5
Abstract
The tetrazole compound which was direct of the ヘテロア reel ingredient containing N which adjoins the joint with which a ヘテロア reel is connected, or was replaced by the connection machine, For example, in dealing with psychiatric impairment and mood disorders, such as schizophrenia, insecurity, depression, and panic, it is mGluR5 useful modifier in dealing with a pain and other diseases.
Term
No projected expiry on record.
- Priority
- Filed
- Granted
- Today
72 members in 9 offices
Priority claims1
| Document | Office | Kind | Date |
|---|---|---|---|
| 32713201 | United States of America | P |
Members72
| Document | Office | Kind | |
|---|---|---|---|
| CA2462289A1 | Canada | A1 | |
| WO03029210A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU2002341921B8 | Australia | B8 | |
| CA2469813A1 | Canada | A1 | |
| CA2469821A1 | Canada | A1 | |
| WO03051315A2 | World Intellectual Property Organization (WIPO) | A2 | |
| WO03051833A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU2002359714A1 | Australia | A1 | |
| AU2002366388A1 | Australia | A1 | |
| CA2470612A1 | Canada | A1 | |
| WO03053922A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU2002360621A1 | Australia | A1 | |
| WO03059904A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU2002364906A1 | Australia | A1 | |
| WO03053922A3 | World Intellectual Property Organization (WIPO) | A3 | |
| WO03051315A3 | World Intellectual Property Organization (WIPO) | A3 | |
| WO03051833A3 | World Intellectual Property Organization (WIPO) | A3 | |
| WO03029210A3 | World Intellectual Property Organization (WIPO) | A3 | |
| WO2004030637A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU2003218462A1 | Australia | A1 | |
| AU2003218462A8 | Australia | A8 | |
| EP1434773A2 | European Patent Office (EPO) | A2 | |
| CA2470519A1 | Canada | A1 | |
| EP1458383A2 | European Patent Office (EPO) | A2 | |
| EP1458385A2 | European Patent Office (EPO) | A2 | |
| EP1458708A2 | European Patent Office (EPO) | A2 | |
| EP1458710A1 | European Patent Office (EPO) | A1 | |
| US2004186295A1 | United States of America | A1 | |
| WO2004030637A3 | World Intellectual Property Organization (WIPO) | A3 | |
| US2004259917A1 | United States of America | A1 | |
| EP1434773A4 | European Patent Office (EPO) | A4 | |
| US2005020585A1 | United States of America | A1 | |
| US2005026963A1 | United States of America | A1 | |
| JP2005508344A | Japan | A | |
| EP1458710A4 | European Patent Office (EPO) | A4 | |
| US2005085514A1 | United States of America | A1 | |
| EP1458383A4 | European Patent Office (EPO) | A4 | |
| JP2005516920A | Japan | A | |
| JP2005516934A | Japan | A | |
| JP2005516950A | Japan | A | |
| JP2005516969A | Japan | A | |
| EP1458708A4 | European Patent Office (EPO) | A4 | |
| EP1458385A4 | European Patent Office (EPO) | A4 | |
| US7105548B2 | United States of America | B2 | |
| AU2002359714B2 | Australia | B2 | |
| AU2002360621B2 | Australia | B2 | |
| AU2002341921B2 | Australia | B2 | |
| US7253190B2 | United States of America | B2 | |
| AU2002364906B2 | Australia | B2 | |
| EP1458708B1 | European Patent Office (EPO) | B1 | |
| AT374194T | Austria | T | |
| DE60222698D1 | Germany | D1 | |
| EP1458383B1 | European Patent Office (EPO) | B1 | |
| DE60223720D1 | Germany | D1 | |
| ES2292854T3 | Spain | T3 | |
| ES2295441T3 | Spain | T3 | |
| US7371767B2 | United States of America | B2 | |
| EP1434773B1 | European Patent Office (EPO) | B1 | |
| AT396186TThis record | Austria | T | |
| DE60222698T2 | Germany | T2 | |
| DE60226756D1 | Germany | D1 | |
| AU2002366388B2 | Australia | B2 | |
| DE60223720T2 | Germany | T2 | |
| CA2469813C | Canada | C | |
| JP4286146B2 | Japan | B2 | |
| JP4299139B2 | Japan | B2 | |
| JP4303109B2 | Japan | B2 | |
| US7569592B2 | United States of America | B2 | |
| CA2469821C | Canada | C | |
| JP4357965B2 | Japan | B2 | |
| CA2470519C | Canada | C | |
| CA2462289C | Canada | C |
1 legal event, as the office reported them to INPADOC
Events
| Event | Code | |
|---|---|---|
| Ceased as to paragraph 5 lit. 3 law introducing patent treatiesCeasedRER | RER |
Numbers
- Application
- 2776076
Titles2
- German
- HETEROARYLSUBSTITUIERTE TETRAZOLMODULATOREN DES METABOTROPISCHEN GLUTAMATREZEPTORS-5
- English
- METABOTROPIC GLUTAMATE RECEPTOR-5 HETEROARYLSUBSTITUTED TETRAZOL MODULATORS
Classification
- CPC, 23
- C07D401/14
- A61P3/04
- C07D401/04
- A61P25/04
- C07D403/04
- A61P25/08
- C07D403/14
- A61P25/14
- C07D405/04
- A61P25/16
- C07D405/14
- A61P25/18
- C07D413/04
- A61P25/20
- C07D417/04
- A61P25/22
- C07D417/14
- A61P25/24
- C07D471/04
- A61P25/28
- A61P25/30
- A61P25/34
- A61P29/00
- IPC, 39
- A61K31 135
- A61K31 41
- A61K31 4155
- A61K31 4178
- A61K31 4184
- A61K31 42
- A61K31 422
- A61K31 4439
- A61K31 4709
- A61K31 4725
- A61K31 485
- A61K31 497
- A61K45 00
- A61P25 04
- A61P25 08
- A61P25 14
- A61P25 16
- A61P25 18
- A61P25 20
- A61P25 22
- A61P25 24
- A61P25 28
- A61P25 30
- A61P25 34
- A61P29 00
- A61P3 04
- C07D401 04
- C07D401 06
- C07D401 12
- C07D401 14
- C07D403 04
- C07D403 14
- C07D405 04
- C07D405 14
- C07D413 04
- C07D413 14
- C07D417 04
- C07D417 14
- C07D471 04